1 Research Methodology
2 Research Objectives
3 Research Process
4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Source Type
4.3.2 Market Segmentation by Methodology
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Currency Conversion rate
5.2 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview Of Nervous System and Neurophysiology
7.2 Introduction to IONM
7.3 Evolution of IONM
7.4 Standard STAGES in IONM
7.4.1 Pre-operative Preparation
7.4.2 Baseline IONM Recording
7.4.3 Perioperative IONM Recording
7.4.4 IONM Documentation
7.4.5 Interpretive Report Preparation
7.5 Key Advantages of IONM
8 Reimbursement Scenario
8.1 Background
8.2 Reimbursement Scenario in North America
8.2.1 Reimbursement Scenario in US
8.2.2 Overview of IONM Reimbursement
8.2.3 Outline of Coding Considerations-
8.3 Reimbursement Scenario in Europe
8.3.1 Reimbursement Scenario in UK
8.3.2 Reimbursement Scenario in France
8.3.3 Reimbursement Scenario in Germany
8.3.4 Reimbursement Scenario in Italy
8.3.5 Reimbursement Scenario in Spain
8.4 Reimbursement Scenario in Latin America
8.4.1 Reimbursement Scenario in Mexico
8.5 Reimbursement Scenario in APAC
8.5.1 Reimbursement Scenario in Japan
8.5.2 Reimbursement Scenario in Australia
9 Market Dynamics
9.1 Market Growth Enablers
9.1.1 Increase in Volume of Surgical Procedures
9.1.2 Increased Utility of IONM in Varied Surgeries
9.1.3 Technological Advancements
9.1.4 Increased Use of Out-sourced IONM by Small and Rural Healthcare Centers
9.1.5 YOY Impact of Market Enablers
9.2 Market Growth Restraint
9.2.1 Low Awareness and Adoption of IONM in Emerging Countries
9.2.2 Limited Skilled Healthcare Professionals
9.2.3 High Cost of IONM Utilized Surgeries
9.2.4 Associated Complications of IONM
9.2.5 YOY Impact of Market Restraints
9.3 Market Opportunities & Trends
9.3.1 High Demand for Tele-Neuromonitoring
9.3.2 Advent of Portable and Multi-modality IONM Devices
9.3.3 Increase in Strategic Consolidation
9.3.4 Integration of MI Surgeries with IONM
9.3.5 YOY Impact of Trends and Opportunities
10 Global IONM Market
10.1 market Overview
10.2 Market Size & Forecast
10.3 Porter’s Five Forces Analysis
10.3.1 Threat of New Entrants
10.3.2 Bargaining Power of Suppliers
10.3.3 Bargaining Power of Buyers
10.3.4 Threat of Substitutes
10.3.5 Competitive Rivalry
11 IONM Market- By Source Type
11.1 Market Overview
11.2 In-Sourced IONM Market
11.3 Outsourced IONM Market
12 IONM Market- By Modality
12.1 Segment Overview
12.2 Evoked Potential (EP) Market
12.2.1 Market Size & Forecast
12.3 Detailed Description of EP Types
12.3.1 Somatosensory evoked potentials (SSEP)
12.3.2 Motor Evoked Potentials (MEP)
12.3.3 Visual Evoked Potential (VEP)
12.3.4 Brainstem Auditory Evoked Potential (BAEP)
12.4 Electromyography (EMG)
12.4.1 Market Size & Forecast
12.4.2 Free-running EMG
12.4.3 Stimulated EMG
12.5 Electroencephalogram (EEG) Market
13 Global IONM Market – By Application
13.1 Segment Overview
13.2 NEURAL Surgeries
13.2.1 Market Size & Forecast
13.3 Orthopedic Surgeries
13.3.1 Market Size & Forecast
13.4 ENT Surgeries
13.4.1 Market Size & Forecast
13.5 Cardiovasular Surgeries
13.5.1 Market Size & Forecast
14 IONM Market - By Geography
14.1 Market Overview
15 North America: IONM Market
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Leading Trends, Enablers, and Restraints
15.4 Key Countries
15.4.1 US: Market Size & Forecast
15.4.2 Canada: Market Size & Forecast
16 Europe: IONM Market
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Leading Trends, Enablers, and Restraints
16.4 Key Countries
16.4.1 Germany: Market Size & Forecast
16.4.2 UK: Market Size & Forecast
16.4.3 France, Italy, and Spain: Market Size and Forecast
17 APAC: IONM Market
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Leading Trends, Enablers, and Restraints
17.4 Key Countries
17.4.1 Japan: Market Size & Forecast
17.4.2 Australia: Market Size & Forecast
17.4.3 China and India: Market Size & Forecast
18 Latin America: IONM Market
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Major Trends, Enablers, and Restraints
18.4 Key Countries
18.4.1 Mexico: Market Size & Forecast
18.4.2 Brazil: Market Size & Forecast
19 Middle East & Africa: IONM Market
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Major Trends, Enablers, and Restraints
20 Competitive Landscape
20.1 Competition overview
21 Key Company Profiles
21.1 SpecialtyCare
21.1.1 Key Highlights
21.1.2 Strength Assessment
21.1.3 Strategy Assessment
21.1.4 Opportunity Assessment
21.2 Natus Medical Incorporated
21.2.1 Key Highlights
21.2.2 Strength Assessment
21.2.3 Strategy Assessment
21.2.4 Opportunity Assessment
21.3 NuVasive Inc
21.3.1 Key Highlights
21.3.2 Strength Assessment
21.3.3 Strategy Assessment
21.3.4 Opportunity Assessment
21.4 Medtronic plc
21.4.1 Key Highlights
21.4.2 Strength Assessment
21.4.3 Strategy Assessment
21.4.4 Opportunity Assessment
21.5 inomed Medizintechnik GmbH
21.5.1 Key Highlights
21.5.2 Strength Assessment
21.5.3 Opportunity Assessment
21.5.4 Strategy Assessment
22 Other Prominent Companies
22.1 Accurate Monitoring
22.1.1 Strength Assessment
22.1.2 Strategy Assessment
22.1.3 Opportunity Assessment
22.2 Cadwell Industries INC.
22.2.1 Strength Assessment
22.2.2 Strategy Assessment
22.2.3 Opportunity Assessment
22.3 Computational Diagnostics INC.
22.3.1 Strength Assessment
22.3.2 Strategy Assessment
22.3.3 Opportunity Assessment
22.4 Bromedicon Neuromonitoring LLC
22.4.1 Strength Assessment
22.4.2 Strategy Assessment
22.4.3 Opportunity Assessment
22.5 Clinical Neurodiagnostics LLC
22.5.1 Strength Assessment
22.5.2 Strategy Assessment
22.5.3 Opportunity Assessment
22.6 CNS Neuromonitoring
22.6.1 Strength Assessment
22.6.2 Strategy Assessment
22.6.3 Opportunity Assessment
22.7 Dr. Langer Medical
22.7.1 Strength Assessment
22.7.2 Strategy Assessment
22.7.3 Opportunity Assessment
22.8 IntraNerve LLC
22.8.1 Strength Assessment
22.8.2 Strategy Assessment
22.8.3 Opportunity Assessment
22.9 Medsurant Health LLC
22.9.1 Strength Assessment
22.9.2 Strategy Assessment
22.9.3 Opportunity Assessment
22.1 Neuro Alert
22.10.1 Strength Assessment
22.10.2 Strategy Assessment
22.10.3 Opportunity Assessment
22.11 Neurophysiology Services Asia
22.11.1 Strength Assessment
22.11.2 Strategy Assessment
22.11.3 Opportunity Assessment
22.12 Nihon Kohden CORP.
22.12.1 Strength Assessment
22.12.2 Strategy Assessment
22.12.3 Opportunity Assessment
23 Report Summary
23.1 Key Takeaways
23.2 Qualitative Summary of Global IONM Market
23.3 Quantitative Summary of Global IONM Market
24 Appendix
24.1 List of Abbreviations